Table 2 Projected estimates associated with each scenario
From: Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
| Â | Baseline CD4 count | Start (Scenario A) | Wait (Scenario B) |
|---|---|---|---|
Life Expectancy, in years | Lowest (250–259) | 18.01 | 15.52 |
|  | Mean (250–350) | 20.93 | 16.96 |
|  | Highest (340–350) | 23.85 | 17.38 |
Discounted Life Expectancy, in years | Lowest (250–259) | 13.91 | 12.41 |
|  | Mean (250–350) | 15.51 | 13.29 |
|  | Highest (340–350) | 17.04 | 13.54 |
YLL | Lowest (250–259) |  | 1.50 |
|  | Mean (250–350) |  | 2.23 |
|  | Highest (340–350) |  | 3.49 |
YLD | Lowest (250–259) |  | −0.17 |
|  | Mean (250–350) |  | −0.25 |
|  | Highest (340–350) |  | −0.39 |
DALY | Lowest (250–259) |  | 1.33 |
|  | Mean (250–350) |  | 1.98 |
|  | Highest (340–350) |  | 3.10 |
Lifetime Cost, cART + Monitoring | Lowest (250–259) | $4,255 | $3,686 |
|  | Mean (250–350) | $4,744 | $3,885 |
|  | Highest (340–350) | $5,210 | $3,870 |
24 Months Hospitalization Cost | Lowest (250–259) | $45 | $254 |
|  | Mean (250–350) | $42 | $389 |
|  | Highest (340–350) | $38 | $565 |
Net Cost | Lowest (250–259) | $4,300 | $3,940 |
|  | Mean (250–350) | $4,786 | $4,274 |
|  | Highest (340–350) | $5,248 | $4,435 |
Cost per DALY | Lowest (250–259) | $270 |  |
|  | Mean (250–350) | $260 |  |
|  | Highest (340–350) | $262 |  |